BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-06-05

Reporting Person: LEWIS ALAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-05	Common Stock	A	4300	—	Acquired	25360	Direct

Footnotes

F1: Restricted stock units granted on June 5, 2018. Price not applicable.

F2: Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 5,000 shares inadvertently included in prior reports based on a reconciliation with the Company's records.